Thus, it is thought that the metabolic disorder arising with CD leads to continuously injured pancreatic acinar cells manifest in elevated levels in the serum of serine protease inhibitor Kazal type 1 (SPINK1), also known as the pancreatic secretory trypsin inhibitor (PSTI).68 This evidence concerns the gene SPINK1 and Other metabolic disease.